Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Raised by Avalon Trust Co

Avalon Trust Co boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 721 shares of the medical equipment provider’s stock after acquiring an additional 166 shares during the quarter. Avalon Trust Co’s holdings in Intuitive Surgical were worth $376,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Choate Investment Advisors raised its position in Intuitive Surgical by 61.8% in the fourth quarter. Choate Investment Advisors now owns 2,370 shares of the medical equipment provider’s stock worth $1,237,000 after acquiring an additional 905 shares in the last quarter. M & L Capital Management Ltd bought a new stake in Intuitive Surgical in the fourth quarter worth about $9,239,000. Frank Rimerman Advisors LLC raised its position in Intuitive Surgical by 0.6% in the fourth quarter. Frank Rimerman Advisors LLC now owns 10,890 shares of the medical equipment provider’s stock worth $5,684,000 after acquiring an additional 60 shares in the last quarter. First National Trust Co increased its stake in Intuitive Surgical by 7.7% in the 4th quarter. First National Trust Co now owns 13,913 shares of the medical equipment provider’s stock worth $7,262,000 after purchasing an additional 994 shares in the last quarter. Finally, Midwest Professional Planners LTD. increased its stake in Intuitive Surgical by 3.4% in the 4th quarter. Midwest Professional Planners LTD. now owns 3,033 shares of the medical equipment provider’s stock worth $1,583,000 after purchasing an additional 100 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $484.44 on Friday. The stock has a market cap of $172.55 billion, a price-to-earnings ratio of 75.58, a PEG ratio of 5.85 and a beta of 1.43. The business has a 50 day simple moving average of $567.46 and a 200 day simple moving average of $531.60. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on ISRG shares. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, CICC Research began coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.